全身化疗和支气管动脉灌注联合CIK过继免疫治疗Ⅲ期非小细胞肺癌的临床研究

背景与目的比较支气管动脉灌注化疗、全身静脉化疗和支气管动脉灌注联合CIK细胞过继免疫治疗Ⅲ期非小细胞肺癌，探讨支气管动脉灌注联合CIK细胞过继免疫治疗中晚期非小细胞肺癌的可行性。

Background and objective To compare therapeutic effect among bronchial arterial infusion （BAI）, traditional vein chemotherapy and BAI plus cytokine-induced killer cells （CIK）, for late NSCLC. Methods A total of 120 patients were enrolled in this study, dividing random into three groups： bronchial arterial infusion （BAI）, traditional vein chemotherapy and BAI plus cytokine- induced killer cells （CIK）. Clinical effects and side effects were estimated after two period of therapy.